GC a good idea. I liked the conference call last time and the chance to ask questions but unfortunately not enough time was allowed for these questions. I would like to see more question time instead of listening to Ross repeat what we had already received before the meeting. A quick summary then straight into some tough questions we as share holders want answered. My questions would be
How low does the share price have to be before directors see enough value to buy (surely we have not been in a blackout for last 6 months) Start showing confidence in the company they are guiding
If we get a good result with oxyC like we hope will a deal be done? (Have we got big pharma waiting in wings) or more test required.
Have we got any particular company guiding our pig trials where a particular end point is met then we will license to them or are we doing trials and HOPING to do a deal like shades of trentinon.
Im sure other posters can come up with quality questions that need answering
- Forums
- ASX - By Stock
- AVE
- Newsletter
AVE
avecho biotechnology limited
Add to My Watchlist
12.5%
!
0.4¢

Newsletter, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $11.10M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $453 | 129.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 33486086 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 8328117 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 33486086 | 0.003 |
15 | 16879866 | 0.002 |
15 | 57221222 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 8328117 | 7 |
0.005 | 13262502 | 18 |
0.006 | 31623747 | 5 |
0.007 | 4498187 | 12 |
0.008 | 4722624 | 6 |
Last trade - 13.52pm 04/07/2025 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online